Cargando…
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies
PURPOSE: The primary objective of this study was to access the potential effects of trabectedin on the QT/QTc interval in patients with locally advanced or metastatic solid tumors. METHODS: Patients (n = 75) who had received ≤3 previous lines of chemotherapy and had either relapsed or had progressiv...
Autores principales: | Thertulien, R., Manikhas, G. M., Dirix, L. Y., Vermorken, J. B., Park, K., Jain, M. M., Jiao, J. J., Natarajan, J., Parekh, T., Zannikos, P., Staddon, A. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265736/ https://www.ncbi.nlm.nih.gov/pubmed/21739119 http://dx.doi.org/10.1007/s00280-011-1697-6 |
Ejemplares similares
-
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies
por: Mendzelevski, Boaz, et al.
Publicado: (2018) -
The Measurement of the QT Interval
por: Postema, Pieter G, et al.
Publicado: (2014) -
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
por: Kaye, S. B., et al.
Publicado: (2011) -
Manual vs. automatic assessment of the QT-interval and corrected QT
por: Neumann, Benjamin, et al.
Publicado: (2023) -
Electrocardiographic Characterization of Ramucirumab on the Corrected QT
Interval in a Phase II Study of Patients With Advanced Solid Tumors
por: Olszanski, Anthony J., et al.
Publicado: (2016)